secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMGEN INC (AMGN)
CIK:        0000318154
Form:       8-K
Filed at:   2024-06-03T23:59:59+00:00
Accession:  0001193125-24-153221
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Amgen stockholders approve 31.3M share increase in equity plan, re-elect all 12 directors
--------------------------------------------------------------------------------

- Stockholders approved Second Amended and Restated 2009 Equity Incentive Plan, adding 31,297,000 shares.
- All 12 director nominees elected; Dr. Mary E. Klotman appointed to committees effective June 1, 2024.
- Advisory vote on executive compensation passed with 93.4% of votes cast in favor.
- Ernst & Young ratified as independent auditor for fiscal year 2024 with 93.7% of votes cast.
- Plan amendments include clarifying dividend-equity payout timing and change-of-control vesting rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/318154/000119312524153221/0001193125-24-153221-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/318154/000119312524153221/d827769d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-153221

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer